Terry Lebold

Terry Lebold has a solid background in the pharmaceutical industry, with experience at Neurocrine Biosciences and The Janssen Pharmaceutical Companies of Johnson & Johnson. They held the position of Principal Scientist at Neurocrine Biosciences starting in January 2023. Prior to this role, Terry worked at The Janssen Pharmaceutical Companies of Johnson & Johnson, first as a Scientist from August 2012 to September 2016, and later as a Senior Scientist from September 2016 to January 2023. Before entering the industry, Terry was a Postdoctoral Scholar at UC Berkeley from July 2010 to June 2012.

Terry Lebold obtained a Doctor of Philosophy (Ph.D.) degree in Organic Chemistry from Western University between 2005 and 2010. Prior to that, Terry attended Western University from 2000 to 2004 and earned a Bachelor of Science (B.Sc.) degree with Distinction in Honors Biochemistry and Chemistry, Scholar's Elective Program.